Teva Branded Pharmaceutical Products R&D, Inc. v. Cipla Ltd.
Teva Branded Pharmaceutical Products R&D, Inc. v. Cipla Ltd.
Opinion
Case: 23-2241 Document: 47 Page: 1 Filed: 02/11/2025
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., NORTON (WATERFORD) LTD., Plaintiffs-Appellees v. CIPLA LTD., Defendant-Appellant ______________________ 2023-2241 ______________________ Appeal from the United States District Court for the District of New Jersey in Nos. 2:20-cv-10172-JXN-MAH, 2:20-cv-14833-JXN-MAH, 2:20-cv-14890-JXN-MAH, Judge Julien X. Neals. ______________________ ON MOTION ______________________ PER CURIAM.
ORDER The parties jointly move to remand the above-cap- tioned appeal to the district court, with each side to bear their own fees and costs.
Upon consideration thereof, Case: 23-2241 Document: 47 Page: 2 Filed: 02/11/2025
2 TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. v. CIPLA LTD.
IT IS ORDERED THAT: The motion is granted.
FOR THE COURT
February 11, 2025 Date
ISSUED AS MANDATE: February 11, 2025
Case-law data current through December 31, 2025. Source: CourtListener bulk data.